Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind study of SYH2069 versus placebo and tirzepatide in adults with type 2 diabetes mellitus inadequately controlled by diet/exercise or metformin
CTR20263304Phase 2Active
- Sponsor
- Beijing Kangchuanglian Biopharmaceutical Technology Research Center
- Start
- Aug 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of SYH2069 in type 2 diabetes mellitus (T2DM), sponsored by Beijing Kangchuanglian Biopharmaceutical Technology Research Center. Started Aug 2026; status: active.
02
Drugs
SYH2069
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20263304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263304.